{"article_title": "Infographic: Rheumatoid Arthritis Drug Costs Increasing Over Time", "article_keywords": ["treating", "increased", "data", "price", "arthritis", "drug", "costs", "infographic", "prices", "increasing", "rheumatoid", "market"], "article_url": "https://morningconsult.com/alert/infographic-rheumatoid-arthritis-drug-costs-expected-to-increase/", "article_text": "An infographic recently released by the Alliance of Community Health Plans shows that prescriptions to treat rheumatoid arthritis have increased since 2013, and projects they will continue to do so through 2020.\n\nFrom January 2013 through January 2016, the price of Enbrel increased 80.3 percent, the price of Humira increased 68.7 percent and the price of Xeljanz increased 44.3 percent. The cost of treating rheumatoid arthritis will increase from $6.4 billion in 2013 to $9.3 billion in 2020, according to data from data cited from the journal Arthritis & Rheumatology.\n\nThe trend goes against what traditionally happens in the pharmaceutical market, which is that drug costs decrease as more generic versions enter the market and drive down costs. Rising drug prices have become a national concern, and have been a major topic on the campaign trail this year.\n\nThe ACHP has been highlighting the price changes of treatments for treating common diseases as part of an infographic series on drug prices.", "article_metadata": {"msapplication-config": "/icons/browserconfig.xml", "og": {"site_name": "Morning Consult", "description": "An infographic\u00a0recently released by the Alliance of Community Health Plans shows that prescriptions to treat rheumatoid arthritis have increased since 2013, and projects they will continue to do so through 2020. From January 2013 through January 2016, the price of Enbrel increased 80.3 percent, the price of Humira increased 68.7 percent and the price of... read more", "title": "Infographic: Rheumatoid Arthritis Drug Costs Increasing Over Time - Morning Consult", "locale": "en_US", "image": "https://morningconsult.com/wp-content/uploads/2016/04/Screen-Shot-2016-04-01-at-3.18.28-PM.png", "url": "https://morningconsult.com/alert/infographic-rheumatoid-arthritis-drug-costs-expected-to-increase/", "type": "article"}, "twitter": {"description": "An infographic\u00a0recently released by the Alliance of Community Health Plans shows that prescriptions to treat rheumatoid arthritis have increased since 2013, and projects they will continue to do so through 2020. From January 2013 through January 2016, the price of Enbrel increased 80.3 percent, the price of Humira increased 68.7 percent and the price of... read more", "title": "Infographic: Rheumatoid Arthritis Drug Costs Increasing Over Time - Morning Consult", "image": "https://morningconsult.com/wp-content/uploads/2016/04/Screen-Shot-2016-04-01-at-3.18.28-PM.png", "creator": "@melmcintire", "site": "@morningconsult", "card": "summary"}, "msapplication-TileColor": "#2b5797", "theme-color": "#ffffff", "msapplication-TileImage": "/icons/mstile-144x144.png", "article": {"publisher": "https://www.facebook.com/Morning-Consult-183517831660100/", "section": "Health"}, "viewport": "width=device-width, initial-scale=1"}, "article_summary": "The cost of treating rheumatoid arthritis will increase from $6.4 billion in 2013 to $9.3 billion in 2020, according to data from data cited from the journal Arthritis & Rheumatology.\nRising drug prices have become a national concern, and have been a major topic on the campaign trail this year.\nThe ACHP has been highlighting the price changes of treatments for treating common diseases as part of an infographic series on drug prices.\nAn infographic recently released by the Alliance of Community Health Plans shows that prescriptions to treat rheumatoid arthritis have increased since 2013, and projects they will continue to do so through 2020.\nThe trend goes against what traditionally happens in the pharmaceutical market, which is that drug costs decrease as more generic versions enter the market and drive down costs."}